Bliss GVS Pharma Limited (NSE:BLISSGVS)
India · Delayed Price · Currency is INR 159.00
-0.60 (-0.38%)
Aug 29, 2025, 9:30 AM IST
Bliss GVS Pharma Market Cap
Bliss GVS Pharma has a market cap or net worth of 16.85 billion as of August 28, 2025. Its market cap has increased by 42.30% in one year.
Market Cap
16.85B
Enterprise Value
16.73B
Revenue
8.34B
Ranking
n/a
PE Ratio
15.80
Stock Price
159.00
Market Cap Chart
Since January 11, 2002, Bliss GVS Pharma's market cap has increased from 10.05M to 16.85B, an increase of 167,509.00%. That is a compound annual growth rate of 36.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2025 | 16.85B | -2.92% |
| Dec 31, 2024 | 17.35B | 33.41% |
| Dec 29, 2023 | 13.01B | 72.15% |
| Dec 30, 2022 | 7.56B | -29.58% |
| Dec 31, 2021 | 10.73B | -48.57% |
| Dec 31, 2020 | 20.87B | 34.02% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,839.66B |
| Divi's Laboratories | 1,643.38B |
| Cipla | 1,276.09B |
| Apollo Hospitals Enterprise | 1,120.59B |
| Mankind Pharma | 1,032.72B |
| Zydus Lifesciences | 994.01B |
| Fortis Healthcare | 691.54B |
| Alkem Laboratories | 648.28B |